go-v.orgdoi

A Phase 1, Open-Label, Randomized, Parallel Group Study to Compare the Pharmacokinetics of Single Subcutaneous Injections of Vedolizumab Administered in Prefilled Syringe Versus Prefilled Syringe in Needle Safety Device in Healthy Subjects

Takeda · Vivli · 2021

  • DOI 10.25934/00007366
  • Publisher Vivli
  • Type dataset
  • Issued 2021

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Vivli · Vivli · dataset · 2021

Abstract

The purpose of this study is to compare the PK of single dose of vedolizumab SC 108 milligram (mg) administered as PFS vs investigational device.

Open the resolved locator · 10.25934/00007366

Metadata licence: OpenAlex metadata (CC0)